These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 26689967)
21. Co-evolution of HIV Envelope and Apex-Targeting Neutralizing Antibody Lineage Provides Benchmarks for Vaccine Design. Rantalainen K; Berndsen ZT; Murrell S; Cao L; Omorodion O; Torres JL; Wu M; Umotoy J; Copps J; Poignard P; Landais E; Paulson JC; Wilson IA; Ward AB Cell Rep; 2018 Jun; 23(11):3249-3261. PubMed ID: 29898396 [TBL] [Abstract][Full Text] [Related]
22. Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model. Voss JE; Andrabi R; McCoy LE; de Val N; Fuller RP; Messmer T; Su CY; Sok D; Khan SN; Garces F; Pritchard LK; Wyatt RT; Ward AB; Crispin M; Wilson IA; Burton DR Cell Rep; 2017 Oct; 21(1):222-235. PubMed ID: 28978475 [TBL] [Abstract][Full Text] [Related]
23. A Bispecific Antibody That Simultaneously Recognizes the V2- and V3-Glycan Epitopes of the HIV-1 Envelope Glycoprotein Is Broader and More Potent than Its Parental Antibodies. Davis-Gardner ME; Alfant B; Weber JA; Gardner MR; Farzan M mBio; 2020 Jan; 11(1):. PubMed ID: 31937648 [TBL] [Abstract][Full Text] [Related]
25. Structural Features of Broadly Neutralizing Antibodies and Rational Design of Vaccine. Zhou T; Xu K Adv Exp Med Biol; 2018; 1075():73-95. PubMed ID: 30030790 [TBL] [Abstract][Full Text] [Related]
26. Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies. LaBranche CC; Henderson R; Hsu A; Behrens S; Chen X; Zhou T; Wiehe K; Saunders KO; Alam SM; Bonsignori M; Borgnia MJ; Sattentau QJ; Eaton A; Greene K; Gao H; Liao HX; Williams WB; Peacock J; Tang H; Perez LG; Edwards RJ; Kepler TB; Korber BT; Kwong PD; Mascola JR; Acharya P; Haynes BF; Montefiori DC PLoS Pathog; 2019 Sep; 15(9):e1008026. PubMed ID: 31527908 [TBL] [Abstract][Full Text] [Related]
27. Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity. Chuang GY; Geng H; Pancera M; Xu K; Cheng C; Acharya P; Chambers M; Druz A; Tsybovsky Y; Wanninger TG; Yang Y; Doria-Rose NA; Georgiev IS; Gorman J; Joyce MG; O'Dell S; Zhou T; McDermott AB; Mascola JR; Kwong PD J Virol; 2017 May; 91(10):. PubMed ID: 28275193 [TBL] [Abstract][Full Text] [Related]
28. Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope. Schoofs T; Barnes CO; Suh-Toma N; Golijanin J; Schommers P; Gruell H; West AP; Bach F; Lee YE; Nogueira L; Georgiev IS; Bailer RT; Czartoski J; Mascola JR; Seaman MS; McElrath MJ; Doria-Rose NA; Klein F; Nussenzweig MC; Bjorkman PJ Immunity; 2019 Jun; 50(6):1513-1529.e9. PubMed ID: 31126879 [TBL] [Abstract][Full Text] [Related]
29. Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies. Mabvakure BM; Scheepers C; Garrett N; Abdool Karim S; Williamson C; Morris L; Moore PL J Virol; 2019 Mar; 93(6):. PubMed ID: 30567996 [TBL] [Abstract][Full Text] [Related]
30. Induction of Tier 1 HIV Neutralizing Antibodies by Envelope Trimers Incorporated into a Replication Competent Vesicular Stomatitis Virus Vector. Bresk CA; Hofer T; Wilmschen S; Krismer M; Beierfuß A; Effantin G; Weissenhorn W; Hogan MJ; Jordan APO; Gelman RS; Montefiori DC; Liao HX; Schmitz JE; Haynes BF; von Laer D; Kimpel J Viruses; 2019 Feb; 11(2):. PubMed ID: 30769947 [TBL] [Abstract][Full Text] [Related]
31. Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies. McGuire AT; Hoot S; Dreyer AM; Lippy A; Stuart A; Cohen KW; Jardine J; Menis S; Scheid JF; West AP; Schief WR; Stamatatos L J Exp Med; 2013 Apr; 210(4):655-63. PubMed ID: 23530120 [TBL] [Abstract][Full Text] [Related]
32. Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins. Schiffner T; Pallesen J; Russell RA; Dodd J; de Val N; LaBranche CC; Montefiori D; Tomaras GD; Shen X; Harris SL; Moghaddam AE; Kalyuzhniy O; Sanders RW; McCoy LE; Moore JP; Ward AB; Sattentau QJ PLoS Pathog; 2018 May; 14(5):e1006986. PubMed ID: 29746590 [TBL] [Abstract][Full Text] [Related]
34. Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D. McGuire AT; Glenn JA; Lippy A; Stamatatos L J Virol; 2014 Mar; 88(5):2645-57. PubMed ID: 24352455 [TBL] [Abstract][Full Text] [Related]
35. A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex. Mishra N; Sharma S; Dobhal A; Kumar S; Chawla H; Singh R; Das BK; Kabra SK; Lodha R; Luthra K J Virol; 2020 Sep; 94(19):. PubMed ID: 32669335 [TBL] [Abstract][Full Text] [Related]
36. Conformational Plasticity in the HIV-1 Fusion Peptide Facilitates Recognition by Broadly Neutralizing Antibodies. Yuan M; Cottrell CA; Ozorowski G; van Gils MJ; Kumar S; Wu NC; Sarkar A; Torres JL; de Val N; Copps J; Moore JP; Sanders RW; Ward AB; Wilson IA Cell Host Microbe; 2019 Jun; 25(6):873-883.e5. PubMed ID: 31194940 [TBL] [Abstract][Full Text] [Related]
37. The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous Neutralization. Schorcht A; Cottrell CA; Pugach P; Ringe RP; Han AX; Allen JD; van den Kerkhof TLGM; Seabright GE; Schermer EE; Ketas TJ; Burger JA; van Schooten J; LaBranche CC; Ozorowski G; de Val N; Bader DLV; Schuitemaker H; Russell CA; Montefiori DC; van Gils MJ; Crispin M; Klasse PJ; Ward AB; Moore JP; Sanders RW J Virol; 2022 Jan; 96(1):e0155221. PubMed ID: 34669426 [TBL] [Abstract][Full Text] [Related]
38. Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs. Hoot S; McGuire AT; Cohen KW; Strong RK; Hangartner L; Klein F; Diskin R; Scheid JF; Sather DN; Burton DR; Stamatatos L PLoS Pathog; 2013 Jan; 9(1):e1003106. PubMed ID: 23300456 [TBL] [Abstract][Full Text] [Related]
39. Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan. Liang Y; Guttman M; Williams JA; Verkerke H; Alvarado D; Hu SL; Lee KK J Virol; 2016 Oct; 90(20):9224-36. PubMed ID: 27489265 [TBL] [Abstract][Full Text] [Related]
40. Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in Rabbits. Jiang X; Totrov M; Li W; Sampson JM; Williams C; Lu H; Wu X; Lu S; Wang S; Zolla-Pazner S; Kong XP J Virol; 2016 Dec; 90(24):11007-11019. PubMed ID: 27707920 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]